Akoya Biosciences Ownership

AKYADelisted Stock  USD 1.29  0.00  0.00%   
Akoya Biosciences holds a total of 49.95 Million outstanding shares. Akoya Biosciences shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 72.58 percent of Akoya Biosciences outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Also note that nearly twenty-one million one hundred sixty-five thousand five hundred ninety-five invesors are currently shorting Akoya Biosciences expressing very little confidence in its future performance.
Some institutional investors establish a significant position in stocks such as Akoya Biosciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Akoya Biosciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Akoya Stock Ownership Analysis

About 73.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.96. Akoya Biosciences had not issued any dividends in recent years. Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. Akoya Biosciences operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 319 people. For more info on Akoya Biosciences please contact Brian McKelligon at 855 896 8401 or go to https://www.akoyabio.com.

Akoya Biosciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Akoya Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Akoya Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Akoya Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Pascal Bamford over a month ago
Disposition of 670 shares by Pascal Bamford of Akoya Biosciences at 1.25 subject to Rule 16b-3
 
Niro Ramachandran over three months ago
Disposition of 2310 shares by Niro Ramachandran of Akoya Biosciences at 1.7 subject to Rule 16b-3
 
Pascal Bamford over three months ago
Disposition of 2567 shares by Pascal Bamford of Akoya Biosciences at 1.63 subject to Rule 16b-3
 
Brian McKelligon over three months ago
Disposition of 8257 shares by Brian McKelligon of Akoya Biosciences at 1.63 subject to Rule 16b-3
 
Brian McKelligon over three months ago
Disposition of 226 shares by Brian McKelligon of Akoya Biosciences at 9.918 subject to Rule 16b-3
 
Pascal Bamford over six months ago
Disposition of 25000 shares by Pascal Bamford of Akoya Biosciences at 12.3 subject to Rule 16b-3
 
Mendel Scott over six months ago
Acquisition by Mendel Scott of 44959 shares of Akoya Biosciences at 2.68 subject to Rule 16b-3
 
Niro Ramachandran over six months ago
Acquisition by Niro Ramachandran of 45000 shares of Akoya Biosciences at 12.3 subject to Rule 16b-3
 
Frederic Pla over six months ago
Acquisition by Frederic Pla of 20000 shares of Akoya Biosciences subject to Rule 16b-3
 
Pascal Bamford over six months ago
Disposition of 50000 shares by Pascal Bamford of Akoya Biosciences at 5.35 subject to Rule 16b-3
 
Brian McKelligon over six months ago
Disposition of 7500 shares by Brian McKelligon of Akoya Biosciences at 0.303 subject to Rule 16b-3
 
Brian McKelligon over a year ago
Disposition of 7500 shares by Brian McKelligon of Akoya Biosciences at 2.084 subject to Rule 16b-3

Akoya Biosciences Outstanding Bonds

Akoya Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Akoya Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Akoya bonds can be classified according to their maturity, which is the date when Akoya Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Akoya Stock

If you are still planning to invest in Akoya Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akoya Biosciences' history and understand the potential risks before investing.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum